Formosa Pharmaceuticals to present novel ADC drug TSY-310 at ASCO 2026
May 22, 2026 | 10:58
Formosa Pharmaceuticals will present preclinical efficacy data on TSY-310, its bispecific antibody-drug conjugate, at the 2026 ASCO Annual Meeting, highlighting the compound's differentiated binding profile in oncology research.
Latest News
Mobile Version